BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32006738)

  • 21. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.
    Chiorean L; Bartos A; Pelau D; Iancu D; Ciuleanu T; Buiga R; Oancea I; Mangrau A; Iancu C; Badea R
    J Med Ultrason (2001); 2015 Apr; 42(2):271-6. PubMed ID: 26576584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
    Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
    World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience in primary hepatic neuroendocrine tumor.
    Jia C; Zhang Y; Xu J; Sun K
    Turk J Gastroenterol; 2012; 23(5):546-51. PubMed ID: 23161300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus.
    Yang B; Li CL; Guo WH; Qin TQ; Jiao H; Fei ZJ; Zhou X; Duan LJ; Liao ZY
    BMC Cancer; 2018 Jan; 18(1):101. PubMed ID: 29378532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations.
    Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
    Cancer Imaging; 2017 Jul; 17(1):20. PubMed ID: 28683830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
    Huang YQ; Xu F; Yang JM; Huang B
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
    Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
    Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
    World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR.
    Tauchmanovà L; Pensabene M; Capuano I; Spagnoletti I; Zeppa P; Del Vecchio S; Mainenti M; De Rosa G; Colao A; Contegiacomo A
    J Endocrinol Invest; 2005 Apr; 28(4):371-8. PubMed ID: 15966513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
    Chen J; Zhang Y; Cai H; Yang Y; Fei Duan Y
    J BUON; 2018; 23(3):629-634. PubMed ID: 30003729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.